Implementing operative eligibility thresholds based on body mass index (BMI) alone risks restricting access to improved pain, function, and quality-of-life. The purpose of this study was to: 1) investigate the relationship between BMI and improvements in 1-year patient reported outcome measures (PROMs), and 2) determine how many patients would have been denied 1-year improvements with specific BMI cut-offs. Data were collected on a prospective cohort of 3,214 TKA patients from 2015–2018. Clinically meaningful 1-year improvements were defined as 15 points for Knee Injury and Osteoarthritis Outcome Scores (KOOS) pain and Physical Function Shortform (PS), and 14 points for Knee-Related Quality-of-Life (KRQOL). For specific BMI cut-offs, the positive predictive value for predicting a failure to improve and number of patients denied surgery to avoid one failed improvement was calculated.Introduction
Methods
With the removal of total hip arthroplasty (THA) from the Centers for Medicare & Medicaid Services (CMS) inpatient-only list, understanding predictors of length of stay (LOS) after THA is critical. Thus, we aimed to determine the influence of patient- and procedure-related risk factors as predictors of >1-day LOS after THA. A prospective cohort of 5,281 patients underwent primary THA between January 2016 and April 2019. Risk factors increased LOS were categorized as patient-related (demographics, smoking status, baseline Veterans RAND 12 Item Health Survey Mental Component Summary score [VR-12 MCS], Charlson Comorbidity Index [CCI], surgical indication, baseline Hip Injury and Osteoarthritis Outcome Score [HOOS] pain subscore and baseline HOOS physical function shortform (HOOS-PS), range of motion, and predicted discharge disposition) or procedure-related (hospital site, surgeon, approach, day of surgery, and surgery start time). By using the Akaike information criterion (AIC) and internally-validated concordance probabilities (C-index) for discriminating a 1-day LOS from a >1-day LOS, we compared performance between a patient-related risk factors only model and a model containing both patient- and procedure-related risk factors.Introduction
Methods
Antibiotic-impregnated bone cement (AIBC) has been used for decades to treat and prevent post-operative infections in joint arthroplasty. Local delivery of antibiotics may theoretically have a bactericidal effect, however evidence supporting this is controversial and literature suggests its prophylactic use in primary total knee arthroplasty (TKA) is seldom justified. With evolving standards of care, historical data is no longer relevant in addressing the efficacy of AIBC in the contemporary TKA. The purpose of this study was to evaluate outcomes following primary TKA using AIBC and regular non-AIBC by comparing rates of surgical site infection (SSI) and prosthetic joint infection (PJI). A retrospective review was conducted of all cemented primary TKA procedures from a large institutional database between January 1, 2015 and December 31st, 2016. This identified 6,073 cases, n=2,613 in which AIBC was used and n=3,460 cases using bone cement without antibiotics. Patients were stratified into low risk and high-risk groups based on age (>65 years), BMI (>40), and Charlson Comorbidity Index (CCI; >3). Medical records were reviewed for diagnoses of SSI (skin and superficial wound infections) and PJI (deep joint infections requiring surgery) over a 2-year postoperative period. Univariate analysis and multivariate regression models were used to ascertain the effects of cement type, patient factors (age, gender, BMI, CCI), operative time, and length of stay on infection rates. Additionally, mixed models (adjusted for gender, age, race, BMI, and CCI) were built to account for surgeon variability.Introduction
Methods
Perioperative hospital adverse events are an issue that every surgeon endeavors to avoid and minimize as much as possible. Even “minor events” such as fever or tachycardia may lead to significant costs due to workup tests, inter-consultations, and/or increased hospital stay. The objective of this study was compare perioperative outcomes (hospital length of stay [LOS], discharge disposition), rates of in-hospital adverse events and transfusion, and postoperative readmission and reoperation rates for simultaneous and staged bilateral direct anterior total hip arthroplasty (DA-THA) patients. A retrospective chart review was conducted on a consecutive series of 411 primary bilateral DA-THAs performed between 2010 and 2016 at a single institution by two fellowship trained surgeons. These were categorized as: (1) simultaneous (same anesthesia, n=122) and (2) staged (different hospitalizations, n=289). The mean time between staged surgeries was 468 days (± 414 days). Baseline patient demographics as well as hospital LOS, discharge disposition (home vs. other), hospital adverse events (i.e., nausea, vomiting, tachycardia, fever, confusion, pulmonary embolism, etc.), blood transfusions, and unplanned hospital readmissions and reoperations within 90 days were collected. Groups were compared using independent –tests, Fisher's exact test, and Pearson Chi-Square.Introduction
Methods